Table 1.
Clinical trials previously reviewed by the Huntington’s Disease Clinical Trials Corner
| Trial name | Intervention | Edition | |
| NCT02519036 | IONIS-HTTRx | IONIS-HTTRx* | September 2017(3) |
| NCT02215616 | LEGATO-HD | Laquinimod | |
| NCT02197130 | Amaryllis | PF-02545920 | |
| NCT02006472 | PRIDE-HD | Pridopidine | |
| NCT03225833 | PRECISION-HD1 | WVE-120101 | February 2018(28) |
| NCT03225846 | PRECISION-HD2 | WVE-120102 | |
| NCT01795859 | FIRST-HD | Deutetrabenazine | |
| NCT02481674 | SIGNAL | VX15/2503 | August 2018(29) |
| NCT00712426 | CREST-E | Creatine | |
| NCT03761849 | GENERATION-HD1 | RG6042* | January 2019(30) |
| NCT03344601 | PACE-HD | Physical activity | |
| NCT02535884 | HD-DBS | Deep brain stimulation | June 2019 |
| NCT02453061 | TRIHEP3 | Triheptanoin |
*IONIS-HTTRx and RG6042 refer to the same molecule.